Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.08% Nasdaq Down0.83%

Meridian Bioscience, Inc. (VIVO)

-NasdaqGS
21.72 Down 0.65(2.91%) 4:00PM EDT
|After Hours : 21.72 Down 0.00 (0.01%) 5:09PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 44,794   48,962   47,108   47,265  
Cost of Revenue16,787  18,088  16,477  16,522  
Gross Profit 28,007   30,874   30,631   30,743  
Operating Expenses
Research Development2,853  2,748  2,711  2,811  
Selling General and Administrative13,528  14,855  12,221  12,679  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 11,626   13,271   15,699   15,253  
Income from Continuing Operations
Total Other Income/Expenses Net(216)(215)(148)276  
Earnings Before Interest And Taxes11,410  13,056  15,551  15,529  
Interest Expense -   -   -   -  
Income Before Tax11,410  13,056  15,551  15,529  
Income Tax Expense3,984  3,906  5,392  5,280  
Minority Interest -   -   -   -  
Net Income From Continuing Ops7,426  9,150  10,159  10,249  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 7,426   9,150   10,159   10,249  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 7,426   9,150   10,159   10,249  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.